Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines
S Liljeqvist, S Ståhl - Journal of biotechnology, 1999 - Elsevier
The first scientific attempts to control an infectious disease can be attributed to Edward
Jenner, who, in 1796 inoculated an 8-year-old boy with cowpox (vaccinia), giving the boy …
Jenner, who, in 1796 inoculated an 8-year-old boy with cowpox (vaccinia), giving the boy …
Use of adenoviral vectors as veterinary vaccines
Vaccines are the most effective and inexpensive prophylactic tool in veterinary medicine.
Ideally, vaccines should induce a lifelong protective immunity against the target pathogen …
Ideally, vaccines should induce a lifelong protective immunity against the target pathogen …
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine …
GA Mayr, J Chinsangaram, MJ Grubman - Virology, 1999 - Elsevier
A recombinant replication-defective human adenovirus serotype 5 vector containing FMDV
capsid, P1-2A, and viral 3C protease coding regions was constructed. Two viral clones were …
capsid, P1-2A, and viral 3C protease coding regions was constructed. Two viral clones were …
Replication-defective bovine adenovirus type 3 as an expression vector
PS Reddy, N Idamakanti, Y Chen, T Whale… - Journal of …, 1999 - Am Soc Microbiol
Although recombinant human adenovirus (HAV)-based vectors offer several advantages for
somatic gene therapy and vaccination over other viral vectors, it would be desirable to …
somatic gene therapy and vaccination over other viral vectors, it would be desirable to …
Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep
Mutwiri, Watts, Lew, Beskorwayne, Papp, Griebel - Immunology, 1999 - Wiley Online Library
The majority of pathogens enter the body through mucosal surfaces and it is now evident
that mucosal immunity can provide effective disease protection. However, the induction of …
that mucosal immunity can provide effective disease protection. However, the induction of …
[PDF][PDF] Novel vaccines from biotechnology
D Rogan, LA Babiuk - Revue Scientifique Et Technique-Office …, 2005 - researchgate.net
Vaccination continues to be the main approach to protecting animals from infectious
diseases. Until recently, all licensed vaccines were developed using conventional …
diseases. Until recently, all licensed vaccines were developed using conventional …
Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge
L Fischer, JP Tronel, C Pardo-David, P Tanner… - Vaccine, 2002 - Elsevier
None of the currently available distemper vaccines provides a satisfactory solution for the
immunization of very young carnivores in the face of maternal-derived immunity. Since …
immunization of very young carnivores in the face of maternal-derived immunity. Since …
Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1
AN Zakhartchouk, C Pyne… - Journal of General …, 1999 - microbiologyresearch.org
To determine the potential of replication-competent (E3-deleted) bovine adenovirus-3 (BAV-
3) as a delivery system for vaccine antigens in calves, we evaluated the ability of …
3) as a delivery system for vaccine antigens in calves, we evaluated the ability of …
Adenoviruses as vectors for delivering vaccines to mucosal surfaces
Immunization of mucosal surfaces has become an attractive route of vaccine delivery
because of its ability to induce mucosal immunity. Although various methods of inducing …
because of its ability to induce mucosal immunity. Although various methods of inducing …
Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing …
S Gogev, N Vanderheijden, M Lemaire, F Schynts… - Vaccine, 2002 - Elsevier
Replication-defective human adenoviruses type 5 (HAd5) expressing the bovine
herpesvirus type 1 (BHV-1) glycoprotein gC or gD under the control of the human …
herpesvirus type 1 (BHV-1) glycoprotein gC or gD under the control of the human …